N-(1-methylpiperidin-4-yl)-5H-spiro[benzo[h]quinazoline-6,4-piperidin]-2-amine | 1234353-30-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: N-(1-methylpiperidin-4-yl)-5H-spiro[benzo[h]quinazoline-6,4-piperidin]-2-amine
• 英文别名: N-(1-methylpiperidin-4-yl)spiro[5H-benzo[h]quinazoline-6,4'-piperidine]-2-amine
• CAS: 1234353-30-0
• 化学式: C₂₂H₂₉N₅
• 分子量: 363.506
• InChiKey: XXMRBTULOANAHR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  27
• 可旋转键数：
  2
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.55
• 拓扑面积：
  53.1
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• Dipeptidyl peptidase inhibitors
  申请人：Syrrx, Inc.

  公开号：US20040242568A1

  公开（公告）日：2004-12-02

  Compounds, pharmaceuticals, kits and methods are provided for use with DPP-IV and other S9 proteases that comprise a compound comprising the formula: 1 wherein Q is selected from the group consisting of CO, SO, SO 2 , or C═NR 9 ; and R 1 , R 2 , R 3 and R 4 are as defined herein.

  提供了与DPP-IV和其他S9蛋白酶一起使用的化合物、制药品、试剂盒和方法，其中包括一个包含以下公式的化合物：1 其中Q是从CO、SO、SO2或C═NR9组成的群体中选择的；而R1、R2、R3和R4如此定义。
• SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS
  申请人：Ali Syed M.

  公开号：US20100239525A1

  公开（公告）日：2010-09-23

  The present invention relates to substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds and methods of treating cell proliferative disorders, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof.

  本发明涉及取代的5,6-二氢-6-苯基苯并[f]异喹啉-2-胺化合物及其合成方法。本发明还涉及含有取代的5,6-二氢-6-苯基苯并[f]异喹啉-2-胺化合物的药物组合物，以及通过将这些化合物和药物组合物用于需要治疗细胞增殖性疾病的受试者来治疗癌症等细胞增殖性疾病的方法。
• US8357694B2
  申请人：——

  公开号：US8357694B2

  公开（公告）日：2013-01-22
• [EN] SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS<br/>[FR] COMPOSÉS DE 5,6-DIHYDRO-6-PHÉNYLBENZO[F]ISOQUINOLÉINE-2-AMINES SUBSTITUÉES
  申请人：ARQULE INC

  公开号：WO2010078421A1

  公开（公告）日：2010-07-08

  The present invention relates to substituted 5,6-dihydro-6- phenylbenzo[f]isoquinolin-2-amine compounds and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds and methods of treating cell proliferative disorders, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof.